AGP Executive Report
Last update: 5 hours agoGene therapy manufacturing push: Cellares and Papillon Therapeutics are partnering to automate production of PPL-001, a gene-corrected cell therapy targeting Friedreich’s ataxia, aiming to speed access for patients with a rare inherited neurodegenerative disease. Eating disorder care upgrade: The Emily Program will offer on-site Spravato (esketamine) for eligible adults with eating disorders plus treatment-resistant depression or major depression with acute suicidal thoughts/behaviors—so patients can stay in coordinated care. Women’s health expansion: Wildflower Health is acquiring Every Mother to broaden access to evidence-based pelvic floor and core recovery support across pregnancy, postpartum, and midlife. Public safety and health fraud: An Ohio doctor was sentenced to six months in jail and ordered to register as a sex offender for secretly recording women in employee restrooms. Food safety alerts: Tesco emailed customers about a Doritos Chilli Heatwave recall due to possible milk allergen mix-ups; Mexico also warned about adulterated tequila linked to deaths. Global health: WHO reports DRC’s Ebola outbreak death toll has reached 930 as it spreads fastest on record. Suicide prevention in clinics: SPiER is integrating evidence-based suicide prevention tools into MEDITECH’s electronic health record to help standardize safer care. Fitness tech: TitanBody teased a next-gen wireless EMS suit with expanded muscle coverage and higher intensity.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.